FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kent Wallner

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Co-author Network

Publications

TOP 3
Al V Taira; Gregory S Merrick; Robert W Galbreath; Kent Wallner; Wayne M Butler
Natural history of clinically staged low- and intermediate-risk prostate cancer treated with monotherapeutic permanent interstitial brachytherapy.
Michael Dattoli; Kent Wallner; Lawrence True; David Bostwick; Jennifer Cash; Richard Sorace
Long-term outcomes for patients with prostate cancer having intermediate and high-risk disease, treated with combination external beam irradiation and brachytherapy.
Al V Taira; Gregory S Merrick; Robert W Galbreath; Wayne M Butler; Kent Wallner; Brian S Kurko; Richard Anderson; Jonathan H Lief
Erectile function durability following permanent prostate brachytherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kent Wallner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Al V Taira; Gregory S Merrick; Robert W Galbreath; Kent Wallner; Wayne M Butler
Natural history of clinically staged low- and intermediate-risk prostate cancer treated with monotherapeutic permanent interstitial brachytherapy.
International journal of radiation oncology, biology, physics 2010;76(2):349-54.
2010: Michael Dattoli; Kent Wallner; Lawrence True; David Bostwick; Jennifer Cash; Richard Sorace
Long-term outcomes for patients with prostate cancer having intermediate and high-risk disease, treated with combination external beam irradiation and brachytherapy.
Journal of oncology 2010;2010():.
2009: Al V Taira; Gregory S Merrick; Robert W Galbreath; Wayne M Butler; Kent Wallner; Brian S Kurko; Richard Anderson; Jonathan H Lief
Erectile function durability following permanent prostate brachytherapy.
International journal of radiation oncology, biology, physics 2009;75(3):639-48.
2009: Al V Taira; Gregory S Merrick; Robert W Galbreath; Wayne M Butler; Kent Wallner; Zachariah A Allen; Jonathan H Lief; Edward Adamovich
Pretreatment serum testosterone and androgen deprivation: effect on disease recurrence and overall survival in prostate cancer patients treated with brachytherapy.
International journal of radiation oncology, biology, physics 2009;74(4):1143-9.
2009: Nathan Bittner; Gregory S Merrick; Hugo Andreini; Walter Taubenslag; Zachariah A Allen; Wayne M Butler; Richard L Anderson; Edward Adamovich; Kent Wallner
Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB.
Urology 2009;74(1):171-6.
2009: Lydia Everly; Gregory S Merrick; Zachariah A Allen; Wayne M Butler; Kent Wallner; Jonathan H Lief; Robert W Galbreath; Edward Adamovich
Prostate cancer control and survival in Vietnam veterans exposed to Agent Orange.
Brachytherapy 2009;8(1):57-62.
2008: Nathan Bittner; Kent Wallner; Gregory Merrick; Peter F Orio; Rizwan Nurani; Lawrence True
The time gap between Pd-103 prostate brachytherapy and supplemental beam radiation does not impact on rectal morbidity or likelihood of cure.
American journal of clinical oncology 2008;31(3):231-6.
2008: Ismail B Tutar; Lixin Gong; Sreeram Narayanan; Sayan D Pathak; Paul S Cho; Kent Wallner; Yongmin Kim
Seed-based transrectal ultrasound-fluoroscopy registration method for intraoperative dosimetry analysis of prostate brachytherapy.
Medical physics 2008;35(3):840-8.
2008: Andrew Herstein; Kent Wallner; Gregory Merrick; Peter F Orio; Ken Thornton; Wayne Butler; Steven Sutlief
There is a wide range of predictive dosimetric factors for I-125 and pd-103 prostate brachytherapy.
American journal of clinical oncology 2008;31(1):6-10.
2008: L Christine Fang; Michael Dattoli; Al Taira; Lawrence True; Richard Sorace; Kent Wallner
Prostatic acid phosphatase adversely affects cause-specific survival in patients with intermediate to high-risk prostate cancer treated with brachytherapy.
Urology 2008;71(1):146-50.
2007: Hiroki Mitsuyama; Kent Wallner; Gregory Merrick; Jeffrey Virgin; Peter F Orio; Bruce Montgomery; Lawrence True
The prognostic significance of Gleason pattern 5 in prostate cancer patients treated with Pd-103 brachytherapy.
American journal of clinical oncology 2007;30(6):597-600.
2007: Rizwan Nurani; Kent Wallner; Gregory Merrick; Jeffrey Virgin; Peter F Orio; Lawrence True
Optimized prostate brachytherapy minimizes the prognostic impact of percent of biopsy cores involved with adenocarcinoma.
The Journal of urology 2007;178(5):1968-73; discussion 1973.
2007: Gregory S Merrick; Sarah Gutman; Hugo Andreini; Walter Taubenslag; David L Lindert; Rodney Curtis; Edward Adamovich; Richard Anderson; Zachariah A Allen; Wayne Butler; Kent Wallner
Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy.
European urology 2007;52(3):715-23.
2007: Michael Dattoli; Kent Wallner; Lawrence True; Jennifer Cash; Richard Sorace
Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features.
Cancer 2007;110(3):551-5.
2007: Al Taira; Gregory Merrick; Kent Wallner; Michael Dattoli
Reviving the acid phosphatase test for prostate cancer.
Oncology (Williston Park, N.Y.) 2007;21(8):1003-10.
2007: Michael Dattoli; Kent Wallner; Lawrence True; Jennifer Cash; Richard Sorace
Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension.
Urology 2007;69(2):334-7.
2007: Peter F Orio; Kent Wallner; Gregory Merrick; Andrew Herstein; Paul Mitsuyama; Ken Thornton; Wayne Butler; Steven Sutlief
Dosimetric parameters as predictive factors for biochemical control in patients with higher risk prostate cancer treated with Pd-103 and supplemental beam radiation.
International journal of radiation oncology, biology, physics 2007;67(2):342-6.
2006: Ismail B Tutar; Sayan D Pathak; Lixin Gong; Paul S Cho; Kent Wallner; Yongmin Kim
Semiautomatic 3-D prostate segmentation from TRUS images using spherical harmonics.
IEEE transactions on medical imaging 2006;25(12):1645-54.
2005: Daniel R Reed; Kent Wallner; ERIC FORD; Amy Mueller; Gregory Merrick; Jeffrey Maki; Steven Sutlief; Wayne Butler
Effect of post-implant edema on prostate brachytherapy treatment margins.
International journal of radiation oncology, biology, physics 2005;63(5):1469-73.
2005: Andrew Herstein; Kent Wallner; Gregory Merrick; Hiroki Mitsuyama; Julius Armstrong; Lawrence True; William Cavanagh; Wayne Butler
I-125 versus Pd-103 for low-risk prostate cancer: long-term morbidity outcomes from a prospective randomized multicenter controlled trial.
Cancer journal (Sudbury, Mass.) 2005;11(5):385-9.
2005: Audrey Tran; Kent Wallner; Gregory Merrick; Jergen Seeberger; Julius Armstrong; Amy Mueller; William Cavanagh; Daniel Lin; Wayne Butler
Rectal fistulas after prostate brachytherapy.
International journal of radiation oncology, biology, physics 2005;63(1):150-4.
2005: Kent Wallner; Kathryn Elliott; Gregory Merrick; Paul Herstein; John Rieke
Malpractice in radiation oncology: redefining the role of the medical expert: in regard to Kagan (Int J Radiat Oncol Biol Phys 2005;61:638-639).
International journal of radiation oncology, biology, physics 2005;62(4):1254-5; author reply 1255.
2005: Kent Wallner; Gregory Merrick; Lawrence True; Tracy Sherertz; Steven Sutlief; William Cavanagh; Wayne Butler
20 Gy versus 44 Gy supplemental beam radiation with Pd-103 prostate brachytherapy: preliminary biochemical outcomes from a prospective randomized multi-center trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;75(3):307-10.
2005: Kent Wallner; Gregory Merrick; Steven Sutlief; Lawrence True; Wayne Butler
High-dose regions versus likelihood of cure after prostate brachytherapy.
International journal of radiation oncology, biology, physics 2005;62(1):170-4.
2005: Elena Nedea; Kent Wallner; Daniel Reed; ERIC FORD; Stephen Sutlief; Amy Mueller; Jeffrey Maki; Gregory Merrick
Extraprostatic seed placement and its effect on seed loss.
Cancer journal (Sudbury, Mass.) 2005;11(2):147-51.
2004: Tracy Sherertz; Kent Wallner; Gregory Merrick; William Cavanagh; Wayne Butler; Daniel Reed; Lawrence True
The prognostic significance of Gleason pattern 5 in prostate cancer patients treated with Pd 103 plus beam radiation therapy.
Cancer journal (Sudbury, Mass.) 2004;10(5):301-6.
2004: Amy Mueller; Kent Wallner; Gregory Merrick; ERIC FORD; Steven Sutlief; William Cavanagh; Wayne Butler
Perirectal seeds as a risk factor for prostate brachytherapy-related rectal bleeding.
International journal of radiation oncology, biology, physics 2004;59(4):1047-52.
2004: Stephen C (Christopher) Hoffelt; Kent Wallner; Gregory Merrick
Epididymitis after prostate brachytherapy.
Urology 2004;63(2):293-6.
2004: Kathryn Elliott; Kent Wallner; Gregory Merrick; Paul Herstein
Medical malpractice of prostate brachytherapy.
Brachytherapy 2004;3(4):231-6.
2004: Kent Wallner; Kathryn Elliott; Gregory Merrick; Maged Ghaly; Jeffrey Maki
Chronic pelvic pain following prostate brachytherapy: a case report.
Brachytherapy 2004;3(3):153-8.
2004: Tracy Sherertz; Kent Wallner; Gregory Merrick; ERIC FORD; Steven Sutlief; William Cavanagh; Wayne Butler; Lawrence True
Factors predictive of rectal bleeding after 103Pd and supplemental beam radiation for prostate cancer.
Brachytherapy 2004;3(3):130-5.
2003: Kent Wallner; Gregory Merrick; Lawrence True; Steven Sutlief; William Cavanagh; Wayne Butler
125I versus 103Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial.
International journal of radiation oncology, biology, physics 2003;57(5):1297-303.
2003: Daniel Reed; Kent Wallner; Gregory Merrick; Steven J. Buskirk; Lawrence True
Clinical correlates to PSA spikes and positive repeat biopsies after prostate brachytherapy.
Urology 2003;62(4):683-8.
2003: Amy Mueller; Kent Wallner; Jacques Corriveau; Sandra Arthurs; Micah Gwinn; Steven Sutlief
A reappraisal of local anesthesia for prostate brachytherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;67(3):309-12.
2003: Ben H Han; Kent Wallner; Gregory Merrick; Kas Badiozamani; Wayne Butler
The effect of interobserver differences in post-implant prostate CT image interpretation on dosimetric parameters.
Medical physics 2003;30(6):1096-102.
2003: Stephen Smith; Kent Wallner; Gregory Merrick; Wayne Butler; Steven Sutlief; Peter D Grimm
Interpretation of pre- versus postimplant TRUS images.
Medical physics 2003;30(5):920-4.
2003: Ben H Han; Kent Wallner; Gregory Merrick; Wayne Butler; Steven Sutlief; John Sylvester
Prostate brachytherapy seed identification on post-implant TRUS images.
Medical physics 2003;30(5):898-900.
2003: Maged Ghaly; Kent Wallner; Gregory Merrick; Lawrence True; Steven Sutlief; William Cavanagh; Wayne Butler
The effect of supplemental beam radiation on prostate brachytherapy-related morbidity: morbidity outcomes from two prospective randomized multicenter trials.
International journal of radiation oncology, biology, physics 2003;55(5):1288-93.
2003: Michael Dattoli; Kent Wallner; Lawrence True; Jennifer Cash; Richard Sorace
Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphatase.
Cancer 2003;97(4):979-83.
2003: Jerry Barker; Kent Wallner; Gregory Merrick
Gross hematuria after prostate brachytherapy.
Urology 2003;61(2):408-11.
2003: Jacques Corriveau; Kent Wallner; Gregory Merrick; Lawrence True; William Cavanagh; Steven Sutlief; Wayne Butler
Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy.
Brachytherapy 2003;2(2):108-13.
2002: Amy Mueller; Kent Wallner; Gregory Merrick; Jacques Courveau; Steven Sutlief; Wayne Butler; Lixin Gong; Paul Cho
Modification of prostate implants based on postimplant treatment margin assessment.
Medical physics 2002;29(12):2782-7.
2002: Shaleah Jones; Kent Wallner; Gregory Merrick; Jacques Corriveau; Steven Sutlief; Lawrence True; Wayne Butler
Clinical correlates of high intraprostatic brachytherapy dose volumes.
International journal of radiation oncology, biology, physics 2002;53(2):328-33.
2002: Jacob Locke; William Ellis; Kent Wallner; William Cavanagh; John C Blasko
Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: a prospective study.
International journal of radiation oncology, biology, physics 2002;52(3):712-9.
2002: Kent Wallner
Prostate brachytherapy under local anesthesia; lessons from the first 600 patients.
Brachytherapy 2002;1(3):145-8.
2002: Jason Rockhill; Kent Wallner; Cory Hoffman; Gregory Merrick; Colleen Simpson; Sandra Arthurs
Prostate brachytherapy in obese patients.
Brachytherapy 2002;1(1):54-60.
2002: Johnathan Nguyen; Kent Wallner; Ben Han; Steven Sutlief
Urinary morbidity in brachytherapy patients with median lobe hyperplasia.
Brachytherapy 2002;1(1):42-7.
2002: Daniel Landis; Kent Wallner; Jacob Locke; William Ellis; Kenneth Russell; William Cavanagh; John C Blasko
Late urinary function after prostate brachytherapy.
Brachytherapy 2002;1(1):21-6.
2002: Kent Wallner; Gregory Merrick; Lawrence True; William Cavanagh; Colleen Simpson; Wayne Butler
I-125 versus Pd-103 for low-risk prostate cancer: morbidity outcomes from a prospective randomized multicenter trial.
Cancer journal (Sudbury, Mass.) 2002;8(1):67-73.
2001: Tracy Sherertz; Kent Wallner; He Wang; Steven Sutlief; Kenneth Russell
Long-term urinary function after transperineal brachytherapy for patients with large prostate glands.
International journal of radiation oncology, biology, physics 2001;51(5):1241-5.
2001: S Smith; Kent Wallner; Jason A Dominitz; B Han; Lawrence True; Steven Sutlief; Kevin G Billingsley
Argon plasma coagulation for rectal bleeding after prostate brachytherapy.
International journal of radiation oncology, biology, physics 2001;51(3):636-42.
2001: B H Han; K C Demel; Kent Wallner; William Ellis; L Young; Kenneth Russell
Patient reported complications after prostate brachytherapy.
The Journal of urology 2001;166(3):953-7.
2001: S Smathers; Kent Wallner; J Sprouse; Lawrence True
Temporary PSA rises and repeat prostate biopsies after brachytherapy.
International journal of radiation oncology, biology, physics 2001;50(5):1207-11.
2001: Roger Ove; Kent Wallner; Kas Badiozamani; T Korjsseon; Steven Sutlief
Standardization of prostate brachytherapy treatment plans.
International journal of radiation oncology, biology, physics 2001;50(1):257-63.
2001: S Hughes; Kent Wallner; Gregory Merrick; S Miller; Lawrence True
Preexisting histologic evidence of prostatitis is unrelated to postimplant urinary morbidity.
International journal of cancer. Journal international du cancer 2001;96 Suppl():79-82.
2000: D Schwartz; Kevin G Billingsley; Kent Wallner
Follow-up care for cancer: making the benefits equal the cost.
Oncology (Williston Park, N.Y.) 2000;14(10):1493-8, 1501; discussion 1502-5.
2000: He Wang; Kent Wallner; Steven Sutlief; John C Blasko; Kenneth Russell; William Ellis
Transperineal brachytherapy in patients with large prostate glands.
International journal of cancer. Journal international du cancer 2000;90(4):199-205.
2000: Kent Wallner; S Smathers; Steven Sutlief; JM Corman; William Ellis
Prostate brachytherapy in patients with median lobe hyperplasia.
International journal of cancer. Journal international du cancer 2000;90(3):152-6.
2000: G Gray; Kent Wallner; J Roof; JM Corman
Cystourethroscopic findings before and after prostate brachytherapy.
Techniques in urology 2000;6(2):109-11.
2000: D A Loblaw; Kent Wallner; Steven J DiBiase; K Russell; John C Blasko; William Ellis
Brachytherapy in patients with small prostate glands.
Techniques in urology 2000;6(2):64-9.
2000: S Smathers; Kent Wallner; Colleen Simpson; J Roof
Patient perception of local anesthesia for prostate brachytherapy.
Seminars in urologic oncology 2000;18(2):142-6.
2000: B Han; Kent Wallner; S Aggarwal; J Armstrong; Steven Sutlief
Treatment margins for prostate brachytherapy.
Seminars in urologic oncology 2000;18(2):137-41.
2000: Steven J DiBiase; Kent Wallner; Kevin S Tralins; Steven Sutlief
Brachytherapy radiation doses to the neurovascular bundles.
International journal of radiation oncology, biology, physics 2000;46(5):1301-7.
1999: S Aggarwal; Kent Wallner; Lawrence True; Kenneth Russell; Steven Sutlief; John C Blasko; William Ellis
Prostate brachytherapy in patients with prior evidence of prostatitis.
International journal of radiation oncology, biology, physics 1999;45(4):867-9.
1999: Michael Dattoli; Kent Wallner; Lawrence True; Richard Sorace; J Koval; Jennifer Cash; Rosa Castillo Acosta; M Biswas; M Binder; B Sullivan; E Lastarria; N Kirwan; D Stein
Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinoma.
International journal of radiation oncology, biology, physics 1999;45(4):853-6.
1999: Kent Wallner; Colleen Simpson; J Roof; Sandra Arthurs; Tammy Korssjoen; Steven Sutlief
Local anesthesia for prostate brachytherapy.
International journal of radiation oncology, biology, physics 1999;45(2):401-6.
1999: S Smathers; Kent Wallner; Tammy Korssjoen; C Bergsagel; R H Hudson; Steven Sutlief; John C Blasko
Radiation safety parameters following prostate brachytherapy.
International journal of radiation oncology, biology, physics 1999;45(2):397-9.
1999: Kevin S Tralins; Kent Wallner
Follow-up costs after external radiation for low risk prostate cancer.
International journal of radiation oncology, biology, physics 1999;44(2):323-6.
1999: Kent Wallner; William Ellis; Kenneth Russell; William Cavanagh; John C Blasko
Use of TRUS to predict pubic arch interference of prostate brachytherapy.
International journal of radiation oncology, biology, physics 1999;43(3):583-5.
1999: Jennifer Bellon; Kent Wallner; William Ellis; Kenneth Russell; William Cavanagh; John C Blasko
Use of pelvic CT scanning to evaluate pubic arch interference of transperineal prostate brachytherapy.
International journal of radiation oncology, biology, physics 1999;43(3):579-81.
1999: Kas Badiozamani; Kent Wallner; William Cavanagh; John C Blasko
Comparability of CT-based and TRUS-based prostate volumes.
International journal of radiation oncology, biology, physics 1999;43(2):375-8.
1999: Kas Badiozamani; Kent Wallner; Steven Sutlief; William Ellis; John C Blasko; Kenneth Russell
Anticipating prostatic volume changes due to prostate brachytherapy.
Radiation oncology investigations 1999;7(6):360-4.
1998: DY Gelblum; Henry Lee; Mark H Bilsky; C Pinola; S Longford; Kent Wallner
Radiographic findings and morbidity in patients treated with stereotactic radiosurgery.
International journal of radiation oncology, biology, physics 1998;42(2):391-5.
1998: Kenneth Hu; Kent Wallner
Clinical course of rectal bleeding following I-125 prostate brachytherapy.
International journal of radiation oncology, biology, physics 1998;41(2):263-5.
1998: Kenneth Hu; Kent Wallner
Urinary incontinence in patients who have a TURP/TUIP following prostate brachytherapy.
International journal of radiation oncology, biology, physics 1998;40(4):783-6.
1998: A Grann; P B Gaudin; Adam Raben; Kent Wallner
Pathologic features from prostate needle biopsy and prognosis after I-125 brachytherapy.
Radiation oncology investigations 1998;6(4):170-4.
1998: J Willins; Kent Wallner
Time-dependent changes in CT-based dosimetry of I-125 prostate brachytherapy.
Radiation oncology investigations 1998;6(4):157-60.
1998: A Grann; Kent Wallner
Prostate brachytherapy in patients with inflammatory bowel disease.
International journal of radiation oncology, biology, physics 1998;40(1):135-8.
1997: J Willins; Kent Wallner
CT-based dosimetry for transperineal I-125 prostate brachytherapy.
International journal of radiation oncology, biology, physics 1997;39(2):347-53.
1997: Kent Wallner; Henry Lee; S Wasserman; Michael Dattoli
Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection.
International journal of radiation oncology, biology, physics 1997;37(3):565-9.
1996: Kent Wallner; J Roy; Louis B Harrison
Low risk of perioperative infection without prophylactic antibiotics for transperineal prostate brachytherapy.
International journal of radiation oncology, biology, physics 1996;36(3):681-3.
1996: Michael Dattoli; Kent Wallner; R Sorace; J Koval; J Cash; Rosa Castillo Acosta; C Brown; J Etheridge; M Binder; R Brunelle; N Kirwan; S Sanchez; D Stein; S Wasserman
103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma.
International journal of radiation oncology, biology, physics 1996;35(5):875-9.
1996: Kent Wallner; J Roy; Louis B Harrison
Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):449-53.
1995: Kent Wallner; J Roy; Louis B Harrison
Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy.
International journal of radiation oncology, biology, physics 1995;32(2):465-71.
1995: Michael J Zelefsky; Steven A Leibel; Kent Wallner; W F Whitmore; Zvi Fuks
Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(2):459-63.
1994: Kent Wallner; J Roy; Michael J Zelefsky; Zvi Fuks; Louis B Harrison
Short-term freedom from disease progression after I-125 prostate implantation.
International journal of radiation oncology, biology, physics 1994;30(2):405-9.
1994: Kent Wallner; J Roy; Michael J Zelefsky; Zvi Fuks; Louis B Harrison
Fluoroscopic visualization of the prostatic urethra to guide transperineal prostate implantation.
International journal of radiation oncology, biology, physics 1994;29(4):863-7.
1994: Lawrence Kleinberg; Kent Wallner; J Roy; Michael J Zelefsky; V E Arterbery; Zvi Fuks; Louis B Harrison
Treatment-related symptoms during the first year following transperineal 125I prostate implantation.
International journal of radiation oncology, biology, physics 1994;28(4):985-90.
1994: C Clifton Ling; J Roy; N Sahoo; Kent Wallner; L Anderson
Quantifying the effect of dose inhomogeneity in brachytherapy: application to permanent prostatic implant with 125I seeds.
International journal of radiation oncology, biology, physics 1994;28(4):971-8.
1993: Michael J Zelefsky; W F Whitmore; Steven A Leibel; Kent Wallner; Zvi Fuks
Impact of transurethral resection on the long-term outcome of patients with prostatic carcinoma.
The Journal of urology 1993;150(6):1860-4.
1993: J N Roy; L L Anderson; Kent Wallner; Zvi Fuks; C Clifton Ling
Tumor control probability for permanent implants in prostate.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1993;28(1):72-5.
1993: J N Roy; Kent Wallner; P J Harrington; C Clifton Ling; L L Anderson
A CT-based evaluation method for permanent implants: application to prostate.
International journal of radiation oncology, biology, physics 1993;26(1):163-9.
1993: Lawrence Kleinberg; Kent Wallner; M G Malkin
Good performance status of long-term disease-free survivors of intracranial gliomas.
International journal of radiation oncology, biology, physics 1993;26(1):129-33.
1993: V E Arterbery; Kent Wallner; J Roy; Zvi Fuks
Short-term morbidity from CT-planned transperineal I-125 prostate implants.
International journal of radiation oncology, biology, physics 1993;25(4):661-7.
1993: M Rosenstein; Kent Wallner; Howard I Scher; C N Sternberg
Treatment of brain metastases from bladder cancer.
The Journal of urology 1993;149(3):480-3.
1991: Zvi Fuks; Steven A Leibel; Kent Wallner; Colin B Begg; W R Fair; L L Anderson; B S Hilaris; W F Whitmore
The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation.
International journal of radiation oncology, biology, physics 1991;21(3):537-47.
1991: J N Roy; Kent Wallner; S T Chiu-Tsao; L L Anderson; C Clifton Ling
CT-based optimized planning for transperineal prostate implant with customized template.
International journal of radiation oncology, biology, physics 1991;21(2):483-9.
1991: Kent Wallner; S T Chiu-Tsao; J Roy; V E Arterbery; W Whitmore; S Jain; Bruce D Minsky; Paul Russo; Zvi Fuks
An improved method for computerized tomography-planned transperineal 125iodine prostate implants.
The Journal of urology 1991;146(1):90-5.
1991: Kent Wallner; S T Chiu-Tsao; J Roy; M Rosenstein; H Smith; Zvi Fuks
A new device to stabilize templates for transperineal I-125 implants.
International journal of radiation oncology, biology, physics 1991;20(5):1075-7.
1991: K D Schupak; Kent Wallner
The role of radiation therapy in the treatment of locally unresectable or metastatic carcinoid tumors.
International journal of radiation oncology, biology, physics 1991;20(3):489-95.
1990: Kent Wallner; D Nori; M J Morse; Pramod C Sogani; W F Whitmore; Zvi Fuks
125iodine reimplantation for locally progressive prostatic carcinoma.
The Journal of urology 1990;144(3):704-6.
1990: J R Gray; Kent Wallner
Reversal of cranial nerve dysfunction with radiation therapy in adults with lymphoma and leukemia.
International journal of radiation oncology, biology, physics 1990;19(2):439-44.
1990: V Massey; Kent Wallner
Patterns of second recurrence of malignant astrocytomas.
International journal of radiation oncology, biology, physics 1990;18(2):395-8.
1989: Kent Wallner; J H Galicich; M G Malkin; E Arbit; George Krol; Marc K Rosenblum
Inability of computed tomography appearance of recurrent malignant astrocytoma to predict survival following reoperation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(10):1492-6.
1989: Kent Wallner; J H Galicich; George Krol; E Arbit; M G Malkin
Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.
International journal of radiation oncology, biology, physics 1989;16(6):1405-9.
1988: Kent Wallner; M F Gonzales; Michael S Edwards; W M Wara; G E Sheline
Treatment results of juvenile pilocytic astrocytoma.
Journal of neurosurgery 1988;69(2):171-6.
1988: Kent Wallner; M Gonzales; G E Sheline
Treatment of oligodendrogliomas with or without postoperative irradiation.
Journal of neurosurgery 1988;68(5):684-8.
1988: Kent Wallner; Lawrence H Pitts; RL Davis; G E Sheline
Radiation therapy for the treatment of non-eight nerve intracranial neurilemmoma.
International journal of radiation oncology, biology, physics 1988;14(2):287-90.
1987: Kent Wallner; G E Sheline; Lawrence H Pitts; W M Wara; RL Davis; E B Boldrey
Efficacy of irradiation for incompletely excised acoustic neurilemomas.
Journal of neurosurgery 1987;67(6):858-63.
1986: Kent Wallner; W M Wara; G E Sheline; RL Davis
Intracranial ependymomas: results of treatment with partial or whole brain irradiation without spinal irradiation.
International journal of radiation oncology, biology, physics 1986;12(11):1937-41.